LakeShore Biopharma Co., Ltd.(LSB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LSB LakeShore Biopharma Co., Ltd.

Market Closed 12-20 16:00:00 EST

2.96

+0.26

+9.63%

盘后3.00

+0.04+1.35%

17:45 EST

High3.50	Low2.60	Vol125.12K
Open2.84	D1 Closing2.70	Amplitude33.33%
Mkt Cap56.48M	Tradable Cap10.65M	Total Shares19.08M
T/O368.23K	T/O Rate3.48%	Tradable Shares3.60M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"LSB","market":"US","secType":"STK","nameCN":"LakeShore Biopharma Co., Ltd.","latestPrice":2.96,"timestamp":1734728400000,"preClose":2.7,"halted":0,"volume":125119,"hourTrading":{"tag":"盘后","latestPrice":3,"preClose":2.96,"latestTime":"17:45 EST","volume":549,"amount":1580.5,"timestamp":1734734726406},"delay":0,"floatShares":3598541,"shares":19080751,"eps":-5.614551,"marketStatus":"Market Closed","change":0.26,"latestTime":"12-20 16:00:00 EST","open":2.84,"high":3.5,"low":2.6,"amount":368232.17048,"amplitude":0.333333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.614551,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.7,"postHourTrading":{"tag":"盘后","latestPrice":3,"preClose":2.96,"latestTime":"17:45 EST","volume":549,"amount":1580.5,"timestamp":1734734726406},"volumeRatio":7.458395637552414},"requestUrl":"/m/hq/s/LSB/tweets","defaultTab":"tweets","newsList":[{"id":"2492176289","title":"LakeShore Biopharma H1 2025 EPS $0.02; Revenue $53.08M","url":"https://stock-news.laohu8.com/highlight/detail?id=2492176289","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492176289?lang=en_us&edition=fundamental","pubTime":"2024-12-19 22:23","pubTimestamp":1734618224,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma H1 2025 EPS $0.02; Revenue $53.08M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/12/42591070/lakeshore-biopharma-h1-2025-eps-0-02-revenue-53-08m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"LakeShore Biopharma H1 2025 EPS $0.02; Revenue $53.08M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSB"],"gpt_icon":0},{"id":"2492754175","title":"Press Release: LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2492754175","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492754175?lang=en_us&edition=fundamental","pubTime":"2024-12-19 22:05","pubTimestamp":1734617100,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance. -- Achieved total revenue of RMB 371.9 million, reflecting a growth of 36.2%. -- Achieved gross profit of RMB 307.3 million, a growth of 39.1% YoY. -- Gross margin increased to 82.6% from 80.9% in the same period of FY2024. loss[1]  of RMB 174.5 million in the same period of FY2024. YSJA Rabies Vaccine Phase III Clinical Trial Approval for Simplified Regimen. On October 25, 2024, the Company received approval from the National Medical Products Administration  in China to conduct a phase III clinical trial evaluating the immunogenicity and safety of a simplified four-dose regimen for its YSJA rabies vaccine. The trial, scheduled to commence in late December 2024, will enroll 2,380 participants and compare the immunogenicity and safety of the YSJA rabies vaccine across two distinct four-dose immunization schedules agai","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","R","BK4232","LSB","BK4022"],"gpt_icon":0},{"id":"2491300926","title":"LSB Industries (LXU): The Small Cap Chemical Stock Hedge Funds Are Watching Closely","url":"https://stock-news.laohu8.com/highlight/detail?id=2491300926","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491300926?lang=en_us&edition=fundamental","pubTime":"2024-12-14 01:46","pubTimestamp":1734111973,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 11 Best Small Cap Chemical Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where LSB Industries Inc.  stands against the other best small cap chemical stocks to buy.Chemical Industry: A Focus on Innovation and Sustainability. The chemical industry plays a crucial role in the global economy, contributing trillions of dollars to the world’s GDP. This sector is essential for producing a wide range of materials used in everyday products, from fertilizers and plastics to pharmaceuticals and construction materials.Ecosystem innovation is also becoming important as companies collaborate with other industry players, research institutions, and startups to develop sustainable solutions. This collaborative approach includes initiatives that aim to promote recycling and material reuse. To strengthen their market position, chem","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/NR2w5oJk_672b240Ypgk0Q--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ad5fbd6cc7298be3466fbdba95fe35d7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/NR2w5oJk_672b240Ypgk0Q--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ad5fbd6cc7298be3466fbdba95fe35d7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-industries-lxu-small-cap-174613068.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LSB","LXU","BK4098","BK4139","CAGR","BK4159","BK4093","BK4590","UAN"],"gpt_icon":0},{"id":"2491606383","title":"LakeShore Biopharma provides update on ongoing investigation involving Yi Zhang","url":"https://stock-news.laohu8.com/highlight/detail?id=2491606383","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491606383?lang=en_us&edition=fundamental","pubTime":"2024-12-13 09:05","pubTimestamp":1734051927,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) announced that the Shenyang Municipal Public Security Bureau in China has initiated criminal investigations into actions ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lakeshore-biopharma-provides-update-on-ongoing-investigation-involving-yi-zhang?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lakeshore-biopharma-provides-update-on-ongoing-investigation-involving-yi-zhang?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LSB","BK4139"],"gpt_icon":0},{"id":"2491367711","title":"LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2491367711","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491367711?lang=en_us&edition=fundamental","pubTime":"2024-12-13 08:57","pubTimestamp":1734051420,"startTime":"0","endTime":"0","summary":"BEIJING, Dec. 12, 2024  -- LakeShore Biopharma Co., Ltd.  , a leading global biopharmaceutical company focused on the innovation and production of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the Shenyang Municipal Public Security Bureau in China  has initiated criminal investigations into actions taken by former chairman of the board of directors Yi Zhang .Recent Developments: In March 2024, Yi Zhang, despite having been dismissed, exploited his temporary control over the Company's Seal to forge contracts and falsify debts to entities controlled by him. Using these documents, he initiated a case with the Kaifeng Arbitration Commission, leading to the freezing of assets and bank accounts of the Company's wholly-owned subsidiary, Liaoning Yisheng Biopharma Co., Ltd., causing substantial operational challenges.Company Stance on Illegal Activities: LakeShore Biopharma will not condone the unlawful actions perpetrated by Yi Zhang during his te","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PgAitqR_oyPazN_t0CzZbw--~B/aD01MzY7dz0xMzM2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a11ff57ac4c16e3a531a4462df47c6c0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PgAitqR_oyPazN_t0CzZbw--~B/aD01MzY7dz0xMzM2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a11ff57ac4c16e3a531a4462df47c6c0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lakeshore-biopharma-provides-ongoing-criminal-005700215.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LSBPW","LSB"],"gpt_icon":0},{"id":"2488697996","title":"LSB Industries Announces Publication of 2023 Sustainability Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2488697996","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488697996?lang=en_us&edition=fundamental","pubTime":"2024-12-04 05:10","pubTimestamp":1733260200,"startTime":"0","endTime":"0","summary":"OKLAHOMA CITY, December 03, 2024----LSB Industries, Inc. ,  today announced the publication of its 2023 Sustainability Report, highlighting the Company's progress in advancing its sustainability efforts. LSB remains focused on its vision of being a leader in the clean energy transition through the production and delivery of low carbon products to multiple end markets. Additionally, the Company prioritizes its involvement in activities that support the long-term sustainability of the business, particularly with respect to its employees, customers, suppliers, the communities where it operates, as well as the environment.\"Since issuing our inaugural Sustainability Report last year, we continue to make progress towards achieving our long-term sustainability goals,\" stated Mark Behrman, Chairman and Chief Executive Officer. \"Sustainability is an ongoing journey and over the past year we have made positive contributions to many of our areas of influence and for many of our key stakeholders. ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/93yWt_kGEeM0qPSL.6GoRg--~B/aD0yNTM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cd8bda1d756ce3cef91eebc03aa2e6d2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/93yWt_kGEeM0qPSL.6GoRg--~B/aD0yNTM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cd8bda1d756ce3cef91eebc03aa2e6d2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-industries-announces-publication-2023-211000822.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GRO","BK4139","LXU","LSB","BK4098"],"gpt_icon":0},{"id":"2485397142","title":"LSB Industries, Inc. (NYSE:LXU) is favoured by institutional owners who hold 54% of the company","url":"https://stock-news.laohu8.com/highlight/detail?id=2485397142","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485397142?lang=en_us&edition=fundamental","pubTime":"2024-11-21 00:41","pubTimestamp":1732120907,"startTime":"0","endTime":"0","summary":"Significantly high institutional ownership implies LSB Industries' stock price is sensitive to their trading actions. 52% of the business is held by the top 8 shareholders. If you want to know who really controls LSB Industries, Inc. , then you'll have to look at the makeup of its share registry. With 54% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises .Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.In the chart below, we zoom in on the different ownership groups of LSB Industries.What Does The Institutional Ownership Tell Us About LSB Industries?While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/53DNnDwGQ.sWa.kpiAGkDg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/800971adf439bdcde1db382e07278edb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/53DNnDwGQ.sWa.kpiAGkDg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/800971adf439bdcde1db382e07278edb"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-industries-inc-nyse-lxu-164147700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LXU","BK4139","LSB","BK4098","NYSE"],"gpt_icon":0},{"id":"2482876956","title":"BRIEF-LSB Industries Appoints John Chandler As An Independent Member Of The Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2482876956","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482876956?lang=en_us&edition=fundamental","pubTime":"2024-11-12 05:42","pubTimestamp":1731361353,"startTime":"0","endTime":"0","summary":"Nov 11 (Reuters) - LSB Industries Inc   :   * LSB INDUSTRIES, INC. APPOINTS JOHN CHANDLER AS AN INDEPENDENT MEMBER OF THE BOARD OF DIRECTORSSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4098","BK4139","LXU","LSB"],"gpt_icon":0},{"id":"2482376994","title":"LSB Industries, Inc. Appoints John Chandler as an Independent Member of the Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2482376994","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482376994?lang=en_us&edition=fundamental","pubTime":"2024-11-12 05:10","pubTimestamp":1731359400,"startTime":"0","endTime":"0","summary":"OKLAHOMA CITY, November 11, 2024----LSB Industries, Inc. ,  today announced that it has appointed John Chandler as an independent member of the Board of Directors  effective November 7, 2024. Mr. Chandler was also appointed to the audit committee of the Board.Mr. Chandler has more than 30 years of experience in the energy industry, predominantly in financial leadership and business development roles. Most recently, he served as Chief Financial Officer  of The Williams Companies  from 2017 to 2022. Prior to that he was CFO of Magellan Midstream Partners from 2002 to 2014. Between 1992 and 2002 he held various finance, planning and business development positions of increasing responsibility at The Williams Companies and MAPCO Inc. Mr. Chandler currently serves as an independent director and Chairman for Matrix Services Company  where he has been on the board since 2017. He also held board seats at Williams Partners , Green Plains Partners , Cone Midstream Partners  and USA Compression Pa","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/RNqyneW2TF_aGbRj1N7FNw--~B/aD0yNTM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/9a653651c8c4ef47c93538c2c066a894","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/RNqyneW2TF_aGbRj1N7FNw--~B/aD0yNTM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/9a653651c8c4ef47c93538c2c066a894"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-industries-inc-appoints-john-211000012.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4144","WRD","BK4585","GPP","BK4098","LU1621767737.EUR","LU0788109394.HKD","LU2237443978.SGD","CNNX","LU1621768115.EUR","MTRX","LU1621768206.USD","LU0368265418.SGD","BK4139","BK4588","GRO","LU2237443549.SGD","IE00BN8TJ469.HKD","WPZ","WMB","BK4590","LU0320765489.SGD","BK4129","LU0208291251.USD","LXU","LU0070302665.USD","IE00BLSP4452.SGD","LU0122376428.USD","BK4179","IE00BBT3K403.USD","IE00BLSP4239.USD","LU2237443382.USD","LU2237443622.USD","LU2384288077.EUR","LSB","USAC","LU1621767810.EUR"],"gpt_icon":0},{"id":"2481904121","title":"LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan","url":"https://stock-news.laohu8.com/highlight/detail?id=2481904121","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481904121?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:00","pubTimestamp":1730984400,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Nov. 07, 2024  -- LakeShore Biopharma Co., Ltd  , a global leader in the discovery, development, manufacturing, and delivery of next-generation vaccines and therapeutic biologics for infectious diseases and cancer, today announced the initiation of its Biologics License Application  submission to the Drug Regulatory Authority of Pakistan  for theconditional approval of its PIKA rabies vaccine for post-exposure prophylaxis. This submission is based on the results that met the primary endpoints of the vaccine’s global pivotal trial and demonstrated the vaccine’s potential to achieve accelerated protection and meet the WHO’s goal of a one-week rabies vaccine regimen to replace the conventional three- or four-week regimens.Dr.Zenaida Mojares, Chief Medical Officer of LakeShore Biopharma, commented, “Our existing rabies vaccine, YSJA, has protected tens of millions of patie","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PgAitqR_oyPazN_t0CzZbw--~B/aD01MzY7dz0xMzM2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a11ff57ac4c16e3a531a4462df47c6c0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PgAitqR_oyPazN_t0CzZbw--~B/aD01MzY7dz0xMzM2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a11ff57ac4c16e3a531a4462df47c6c0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lakeshore-biopharma-initiates-biologics-license-130000339.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765646.SGD","LU1244550494.USD","LSBPW","LU1894683264.USD","BK4139","LSB","BK4550","BK4504","BK4566","BK4533","LU1894683348.USD","BK4177","LU1162221912.USD","BK4534","PEP","BK4581","LU1929549753.HKD","BK4585","LU1244550577.SGD","BK4588","LU0234572021.USD","IE00B3T34201.USD","LU1244550221.USD"],"gpt_icon":0},{"id":"2481533166","title":"LSB Industries Price Target Maintained With a $10.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2481533166","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481533166?lang=en_us&edition=fundamental","pubTime":"2024-11-05 00:15","pubTimestamp":1730736900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXU/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 04, 2024 11:15 ET (16:15 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSB","LXU"],"gpt_icon":0},{"id":"2480157857","title":"LakeShore Biopharma Announces Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2480157857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480157857?lang=en_us&edition=fundamental","pubTime":"2024-11-02 04:32","pubTimestamp":1730493160,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) has released an update. LakeShore Biopharma announced the resignation of its head of marketing and sales, Mr. Gang Li, ef...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-announces-leadership-transition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-announces-leadership-transition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LSB"],"gpt_icon":0},{"id":"2479707065","title":"Deutsche Bank Lifts Price Target on LSB Industries to $10 From $9, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2479707065","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479707065?lang=en_us&edition=fundamental","pubTime":"2024-10-31 19:37","pubTimestamp":1730374650,"startTime":"0","endTime":"0","summary":"LSB Industries (LXU) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $8 to $15.(MT Newswires covers equity, commodity and economic r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DB","LXU","LSB"],"gpt_icon":0},{"id":"2479706722","title":"LSB Industries Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2479706722","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479706722?lang=en_us&edition=fundamental","pubTime":"2024-10-31 18:20","pubTimestamp":1730370016,"startTime":"0","endTime":"0","summary":"NYSE:LXU Earnings and Revenue Growth October 31st 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 13%. Earnings per share  missed analyst estimates significantly.Looking ahead, revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in the US.The company's shares are down 6.7% from a week ago.Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of LSB Industries' balance sheet and an in-depth analysis of the company's financial position.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-industries-third-quarter-2024-102016663.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LXU","LSB"],"gpt_icon":0},{"id":"2479722971","title":"LSB Industries Inc (LXU) Q3 2024 Earnings Call Highlights: Strategic Turnaround and Expansion ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2479722971","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479722971?lang=en_us&edition=fundamental","pubTime":"2024-10-31 15:11","pubTimestamp":1730358696,"startTime":"0","endTime":"0","summary":"Adjusted EBITDA: $17 million, a significant improvement over the previous year.GAAP Loss Per Share: $0.35, including $16 million in turnaround expenses and $6 million in noncash charges.Natural Gas Costs: Averaged approximately $2.60 per MMBTU quarter to date.Ammonia Pricing: Tampa ammonia averaged $560 per metric ton quarter to date.UAN Pricing: Nola UAN around $230 per ton.Turnaround Expenses: Estimated $15 million for the Cherokee facility in Q4 2024.GuruFocus has detected 3 Warning Signs with LXU.For the complete transcript of the earnings call, please refer to the full earnings call transcript.LSB Industries Inc  reported a significant year-over-year improvement in adjusted EBITDA despite undergoing a major turnaround at their Pryor facility.LSB Industries Inc  expanded its Urea plant at Pryor, which is expected to produce an additional 75,000 tons per year of UAN, marking a 20% annual increase.The company completed the construction of additional nitric acid storage at the El Dora","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.R7QdYsGPKINYRpb0ee6ig--~B/aD0xODA7dz0xODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/12fc31bfc1681f20fbfcff3446d0238f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.R7QdYsGPKINYRpb0ee6ig--~B/aD0xODA7dz0xODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/12fc31bfc1681f20fbfcff3446d0238f"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-industries-inc-lxu-q3-071136647.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LSB","LXU"],"gpt_icon":0},{"id":"2479215114","title":"LSB Industries Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2479215114","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479215114?lang=en_us&edition=fundamental","pubTime":"2024-10-30 11:03","pubTimestamp":1730257392,"startTime":"0","endTime":"0","summary":"* LSB Industries Inc    reported quarterly breakeven results per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -6 cents.  The mean ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSB","LXU"],"gpt_icon":0},{"id":"2479257380","title":"LSB: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2479257380","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479257380?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:34","pubTimestamp":1730234059,"startTime":"0","endTime":"0","summary":"OKLAHOMA CITY  — OKLAHOMA CITY  — LSB Industries Inc.  on Tuesday reported a loss of $25.4 million in its third quarter.The Oklahoma City-based company said it had a loss of 35 cents per share. Losses, adjusted for non-recurring costs, were 11 cents per share.The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.The chemical maker posted revenue of $109.2 million in the period.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-q3-earnings-snapshot-203419993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LXU","LSB"],"gpt_icon":0},{"id":"2479325420","title":"LSB Industries Q3 2024 Adj. EPS $(0.11) Misses $(0.07) Estimate, Sales $109.217M Beat $95.860M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2479325420","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479325420?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:28","pubTimestamp":1730233728,"startTime":"0","endTime":"0","summary":"LSB Industries (NYSE:LXU) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.07) by 57.14 percent.  The company reported quarterly sales of $109.217 million which beat the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/10/41611489/lsb-industries-q3-2024-adj-eps-0-11-misses-0-07-estimate-sales-109-217m-beat-95-860m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSB","LXU"],"gpt_icon":0},{"id":"2479252858","title":"LSB Industries reports Q3 EPS (35c), consensus (7c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2479252858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479252858?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:22","pubTimestamp":1730233327,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue $109.2M, consensus $95.86M. The third quarter 2024 diluted EPS included approximately (24c) per share of turnaround costs and on...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lsb-industries-reports-q3-eps-35c-consensus-7c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lsb-industries-reports-q3-eps-35c-consensus-7c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LSB"],"gpt_icon":0},{"id":"2479251116","title":"BRIEF-LSB Industries Q3 Sales USD 109.217 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2479251116","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479251116?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:10","pubTimestamp":1730232646,"startTime":"0","endTime":"0","summary":"Oct 29 (Reuters) - LSB Industries Q3 net income USD -25.382 million. * Q3 operating income USD -24.423 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSB","USD","LXU"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ysbiopharma.com","stockEarnings":[{"period":"1week","weight":0.1864},{"period":"1month","weight":0.1298},{"period":"3month","weight":-0.6156},{"period":"6month","weight":-0.5067},{"period":"1year","weight":-0.4196},{"period":"ytd","weight":-0.4207}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.","exchange":"NASDAQ","name":"LakeShore Biopharma Co., Ltd.","nameEN":"LakeShore Biopharma Co., Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LakeShore Biopharma Co., Ltd.(LSB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LakeShore Biopharma Co., Ltd.(LSB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LakeShore Biopharma Co., Ltd.,LSB,LakeShore Biopharma Co., Ltd.股票,LakeShore Biopharma Co., Ltd.股票老虎,LakeShore Biopharma Co., Ltd.股票老虎国际,LakeShore Biopharma Co., Ltd.行情,LakeShore Biopharma Co., Ltd.股票行情,LakeShore Biopharma Co., Ltd.股价,LakeShore Biopharma Co., Ltd.股市,LakeShore Biopharma Co., Ltd.股票价格,LakeShore Biopharma Co., Ltd.股票交易,LakeShore Biopharma Co., Ltd.股票购买,LakeShore Biopharma Co., Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LakeShore Biopharma Co., Ltd.(LSB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LakeShore Biopharma Co., Ltd.(LSB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}